XprESS
Commercial- Indications
- Chronic sinusitis
Company intelligence / Profile preview
Entellus Medical
Plymouth / Minneapolis / Maple Grove, Minnesota, United Statesaccessdata.fda.gov ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Commercial
01
Overview
Entellus Medical developed and commercialized minimally invasive devices for the treatment of chronic sinusitis and related ENT conditions. Its products are FDA-cleared and in commercial use. The company’s FinESS Sinus Treatment and XprESS Multi-Sinus Dilation System have demonstrated reduced pain/bleeding and faster recovery compared to traditional surgery.
- Therapeutic areas
- OtolaryngologyPulmonology
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Entellus Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Entellus Medical.